Table 2.

Comparison of MHR, hematology parameters and tumor markers between CRC patients and healthy controls

Indicators	Colorectal cancer	Controls	F	P
N	202	201
Age	60.65 ± 12.23	59.37 ± 7.67	45.57	0.210
ALT	20.20 ± 15.47	23.72 ± 12.98	0.23	0.014
AST	26.83 ± 15.24	24.86 ± 8.12	10.12	0.106
Total protein	68.22 ± 8.41	72.87 ± 4.88	29.14	< 0.001
Total cholesterol	4.81 ± 1.04	4.44 ± 0.69	1053	< 0.001
Triglyceride	1.56 ± 1.25	1.13 ± 0.36	44.53	< 0.001
Monocyte count	0.64 ± 0.30	0.42 ± 0.10	28.50	< 0.001
HDL-C	1.17 ± 0.31	1.32 ± 0.20	29.87	< 0.001
LDL-C	3.01 ± 0.86	2.91 ± 0.17	147.74	0.081
CA153	10.79 ± 6.64	11.08 ± 5.77	43.58	0.637
MHR	0.58 ± 0.29	0.33 ± 0.10	61.48	< 0.001
CEA	3.78 (0.50–160.25)	2.12 (0.50–12.39)	65.27	< 0.001
CA199	10.85 (0.00–693.55)	6.60 (2.00–38.46)	77.29	< 0.001
CA125	10.05 (2.90–203.50)	10.50 (2.50–41.50)	43.58	0.502

The P value was calculated by Independent-Samples T-test/ Mann–Whitney U-test

ALT alanine aminotransferase, AST aspartate aminotransferase, CA125 carbohydrate antigen 125, CA153 carbohydrate antigen 153, CA199 carbohydrate antigen 199, CEA carcinoembryonic antigen, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, MHR monocytes to high-density lipoprotein cholesterol ratio